Good afternoon :)
Place Order
Add to Watchlist

Genpharmasec Ltd

GENPHARMA

Genpharmasec Ltd

GENPHARMA
IndustrialsCommodities Trading
SmallcapWith a market cap of ₹166 cr, stock is ranked 2,639
High RiskStock is 4.24x as volatile as Nifty
3.164.98% (+0.15)
3.164.98% (+0.15)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
IndustrialsCommodities Trading
SmallcapWith a market cap of ₹166 cr, stock is ranked 2,639
High RiskStock is 4.24x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

IndustrialsCommodities Trading
SmallcapWith a market cap of ₹166 cr, stock is ranked 2,639
High RiskStock is 4.24x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
200.812.58
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
50.517.170.54%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Generic Pharmasec Ltd is an India-based company. The Company is focused on trading and dealing in chemicals.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2023FY 2024TTM
Total Revenue25.6231.0729.58
Raw Materialssubtract23.1823.4027.48
Power & Fuel Costsubtract0.000.00
Employee Costsubtract0.540.76
Selling & Administrative Expensessubtract0.953.36
Operating & Other expensessubtract0.582.84
Depreciation/Amortizationsubtract0.020.040.61
Interest & Other Itemssubtract0.060.410.33
Taxes & Other Itemssubtract-0.840.380.33
EPS0.02-0.000.01
DPS0.000.000.00
Payout ratio0.000.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
IndustrialsCommodities Trading

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Genpharmasec Ltd-1,388.912.58
Adani Enterprises Ltd89.586.570.05%
MMTC Ltd62.827.43
MSTC Ltd25.425.842.10%

Price Comparison

Compare GENPHARMA with any stock or ETF
Compare GENPHARMA with any stock or ETF
GENPHARMA
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Decreased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 1.31%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding29.98%0.00%0.00%0.00%70.02%

Feb 2024

Mar 2024

Jun 2024

Sep 2024

Shareholding History

SepDec '23FebMarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

GENPHARMA has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Dividends

Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Earnings
Genpharmasec consolidated net profit rises 6900.00% in the September 2024 quarter

Net profit of Genpharmasec rose 6900.00% to Rs 0.70 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales declined 23.28% to Rs 6.03 crore in the quarter ended September 2024 as against Rs 7.86 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales6.037.86 -23 OPM %1.99-0.51 - PBDT0.810.05 1520 PBT0.500.05 900 NP0.700.01 6900 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Genpharmasec standalone net profit rises 9900.00% in the September 2024 quarter

Net profit of Genpharmasec rose 9900.00% to Rs 1.00 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales declined 26.59% to Rs 5.77 crore in the quarter ended September 2024 as against Rs 7.86 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales5.777.86 -27 OPM %4.33-0.38 - PBDT1.070.05 2040 PBT1.030.05 1960 NP1.000.01 9900 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Genpharmasec announces board meeting date

Genpharmasec will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Earnings
Genpharmasec standalone net profit rises 1866.67% in the June 2024 quarter

Net profit of Genpharmasec rose 1866.67% to Rs 0.59 crore in the quarter ended June 2024 as against Rs 0.03 crore during the previous quarter ended June 2023. Sales declined 11.07% to Rs 5.30 crore in the quarter ended June 2024 as against Rs 5.96 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales5.305.96 -11 OPM %4.150.50 - PBDT0.730.08 813 PBT0.730.07 943 NP0.590.03 1867 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Genpharmasec to conduct board meeting

Genpharmasec will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Generic Pharmasec reports standalone net loss of Rs 0.61 crore in the September 2021 quarter

3 years agoBusiness Standard

Generic Pharmasec Ltd. successfully executes an order from Reliance Group

3 years agoBusiness Standard

Generic Pharmasec successfully executes order from Reliance Group

3 years agoIndia Infoline

Generic Pharmasec standalone net profit rises 445.65% in the March 2021 quarter

3 years agoBusiness Standard

Generic Pharmasec enters into agreement with Abbott Point of Care (APOC)

3 years agoIndia Infoline